The Role of Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 in the p38/TNF-α Pathway of Systemic and Cutaneous Inflammation
- 1 February 2010
- journal article
- Published by Elsevier BV in Journal of Investigative Dermatology
- Vol. 130 (2), 481-491
- https://doi.org/10.1038/jid.2009.218
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Targeting innate immunity protein kinase signalling in inflammationNature Reviews Drug Discovery, 2009
- Reduced Oxazolone-Induced Skin Inflammation in MAPKAP Kinase 2 Knockout MiceJournal of Investigative Dermatology, 2009
- MK2: a novel molecular target for anti-inflammatory therapyEmerging Therapeutic Targets, 2008
- Protein kinases as small molecule inhibitor targets in inflammation.Current Medicinal Chemistry, 2007
- MK2 controls the level of negative feedback in the NF-κB pathway and is essential for vascular permeability and airway inflammationThe Journal of Experimental Medicine, 2007
- Pyrrolopyridine Inhibitors of Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MK-2)Journal of Medicinal Chemistry, 2007
- MAPKAP kinases — MKs — two's company, three's a crowdNature Reviews Molecular Cell Biology, 2006
- Potential Adverse Effects Associated with Inhibition of p38α/β MAP KinasesCurrent Topics in Medicinal Chemistry, 2005
- Deficiency of the Stress Kinase P38α Results in Embryonic LethalityThe Journal of Experimental Medicine, 2000
- Temporal infiltration of leukocyte subsets into mouse skin inflamed with phorbol esterInflammation Research, 1992